Orchid Pharma gets EIR report from USFDA for Alathur facility

21 Sep 2017 Evaluate

Orchid Pharma has received the Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) based on the successful inspection of the Active Pharmaceutical Ingredients (API) manufacturing facility located at SIDCO Industrial Estate, Alathur, Kanchipuram District, Tamil Nadu, India. This facility was inspected by US FDA in May 2017.

Orchid Pharma is a pharmaceutical company engaged in development and manufacture of active pharmaceutical ingredients and finished dosage forms. It is also engaged in research of new drugs.

Orchid Pharma Share Price

655.85 -12.55 (-1.88%)
23-Feb-2026 11:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1722.50
Dr. Reddys Lab 1293.15
Cipla 1321.80
Zydus Lifesciences 901.35
Lupin 2241.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×